38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
1	Is a	General adjectival modifier	false	Inferred relationship	Some
1	Is a	Number	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	3
Product containing precisely naphazoline hydrochloride 200 microgram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely naphazoline hydrochloride 200 microgram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Cetirizine hydrochloride 5 mg chewable tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Cetirizine hydrochloride 5 mg chewable tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 1 mg oral capsule	Has presentation strength numerator value	False	1	Inferred relationship	Some	1
Polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 1 mg oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 1 mg oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Potassium chloride 600 mg prolonged-release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Some
Potassium chloride 600 mg prolonged-release oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely gentamicin sulfate 3 milligram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely gentamicin sulfate 3 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely trimethadione 150 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely trimethadione 150 milligram/1 each conventional release chewable tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely fluorometholone 1 milligram/1 milliliter conventional release eye suspension (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely fluorometholone 1 milligram/1 milliliter conventional release eye suspension (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely fluorometholone 1 milligram/1 milliliter conventional release eye suspension (clinical drug)	Has concentration strength numerator value	False	1	Inferred relationship	Some	1
Olanzapine 5 mg orodispersible tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Olanzapine 5 mg orodispersible tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Fentanyl 800 microgram buccal film	Count of base of active ingredient	False	1	Inferred relationship	Some
Fentanyl 800 microgram buccal film	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Estropipate only product in oral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing only estropipate in vaginal dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Potassium chloride 1.5 g prolonged-release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Potassium chloride 1.5 g prolonged-release oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Desloratadine 2.5 mg orodispersible tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Desloratadine 2.5 mg orodispersible tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	3
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely mirtazapine 30 milligram/1 each conventional release orodispersible tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely mirtazapine 30 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	3
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely sodium salicylate 650 milligram/1 each gastro-resistant oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely sodium salicylate 650 milligram/1 each gastro-resistant oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Cetirizine hydrochloride 10 mg chewable tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Cetirizine hydrochloride 10 mg chewable tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Fentanyl 400 microgram buccal tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Fentanyl 400 microgram buccal tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Doxycycline (as doxycycline hyclate) 150 mg gastro-resistant oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Doxycycline (as doxycycline hyclate) 150 mg gastro-resistant oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely nystatin 500000 unit/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely nystatin 500000 unit/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely ergocalciferol 50000 unit/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely ergocalciferol 50000 unit/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely famotidine 10 milligram/1 each conventional release chewable tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely famotidine 10 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely bupropion hydrobromide 522 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely bupropion hydrobromide 522 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely pilocarpine hydrochloride 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely pilocarpine hydrochloride 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	3
Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	3
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely fluorometholone 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely fluorometholone 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Paracetamol only product in oromucosal dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely olanzapine 10 milligram/1 each conventional release orodispersible tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely olanzapine 10 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely memantine hydrochloride 21 milligram/1 each prolonged-release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely memantine hydrochloride 21 milligram/1 each prolonged-release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Nicotinic acid 250 mg prolonged-release oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Nicotinic acid 250 mg prolonged-release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely fentanyl 200 microgram/1 each conventional release buccal tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely fentanyl 200 microgram/1 each conventional release buccal tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL eye suspension	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Loteprednol etabonate 5 mg/mL eye suspension	Count of base of active ingredient	False	1	Inferred relationship	Some
Erythromycin ethyl succinate 200 mg chewable tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Erythromycin ethyl succinate 200 mg chewable tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely axitinib 1 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely axitinib 1 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely axitinib 1 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	False	1	Inferred relationship	Some	1
Product containing precisely diclofenac sodium 1 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength numerator value	False	1	Inferred relationship	Some	1
Product containing precisely diclofenac sodium 1 milligram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely diclofenac sodium 1 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Topiramate 50 mg oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Some
Topiramate 50 mg oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely pramipexole dihydrochloride 1.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely pramipexole dihydrochloride 1.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely pramipexole dihydrochloride 4.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely pramipexole dihydrochloride 4.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Fentanyl 300 microgram buccal tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1

Start Previous Page 172 of 215 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core